PNC Financial Services Group’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.03K Buy
329
+150
+84% +$1.25K ﹤0.01% 4576
2025
Q4
$1.86K Buy
179
+15
+9% +$151 ﹤0.01% 4543
2025
Q3
$1.47K Buy
+164
New +$1.44K ﹤0.01% 4579
2025
Q2
Sell
-8
Closed -$202 5055
2025
Q1
$202 Buy
8
+3
+60% +$89 ﹤0.01% 4778
2024
Q4
$172 Sell
5
-82
-94% -$3.7K ﹤0.01% 4660
2024
Q3
$4.3K Sell
87
-3
-3% -$154 ﹤0.01% 4085
2024
Q2
$5.42K Buy
90
+56
+165% +$3.2K ﹤0.01% 3975
2024
Q1
$1.75K Buy
+34
New +$1.67K ﹤0.01% 4232

Other funds holding RXST

PNC Financial Services Group's RXST Position: Q1 2026 in Review

PNC Financial Services Group increased its RxSight (RXST) stake by 84% in Q1 2026, buying an estimated $1.25K and bringing the position to 329 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #4576.

PNC Financial Services Group first reported a position in RXST in Q1 2024 and has held it in 8 quarters since. The position peaked at $5.42K in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • PNC Financial Services Group held 329 shares of RxSight worth $2.03K as of Q1 2026.
  • PNC Financial Services Group bought 150 RxSight shares in Q1 2026, an estimated $1.25K.
  • RxSight made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4576 holding.
  • PNC Financial Services Group first reported a position in RxSight in Q1 2024 and has held it in 8 quarters since.
  • PNC Financial Services Group's RxSight position peaked at $5.42K in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.